Welcome to the

2022 SAPA Scientific Symposium

in Virtual on May 21

The Sino-American Pharmaceutical Professionals Association (SAPA) will hold 2022 SAPA Scientific Symposium virtually on Saturday, May 21, 2022. The symposium will focus on the current trends in biomedical industries, and innovation and breakthroughs in the following areas: current advances in drug discovery, CMC challenges and solutions in the development of innovative modalities, design and data in drug development, and new movements in diagnostics. This event is cohosted by SAPA-HQ, SAPA-CT and SAPA-DC.

This year, many world-renowned scientists, entrepreneurs, as well as senior executives of leading pharmaceutical companies will gather in the scientific symposium to share their perspectives of the hottest topics and recent advancement in the field of biotechnologies and pharmaceutical science. You will have opportunities to learn the first-hand news of the breakthroughs in anti-cancer therapy (e.g., CAR-T towards a cure of multiple myeloma, immunotherapy combination therapies in solid tumor oncology, RNA nanoparticles for cancer drug delivery and PROTAC technology); discover how artificial intelligence (AI) and deep learning are going to change the way we move forward in drug discovery and development; and dive deep into the diagnostic application of metagenomic next-generation sequencing (mNGS). Coming out of the symposium, you’ll likely gain more understanding of the current landscape of the biotechnology and pharmaceutical industry. 

In addition, a job fair will be hosted at the end of the day for job-seekers. Companies including Accurant Biotech, Ascendia (Formulation Scientist/Analytical R&D Scientist/Microbiologis), GemPharmaTech, and Aleon (Project Manager, Regulatory Operations Project Management, Regulatory Affairs – Preclinical), will attend the virtual job fair. You are also welcome to attend an in-person gathering and networking event on May 22 to make more connections and establish personal relationships with other attendees! The offline networking event is free for scientific syposium participitants. The space is limited for this special after-conference networking opportunity on a first-come-first-serve basis.

Registration

Ticket Type Price Cart
General Entry $20
Add to Cart
Student Ticket (Please use ".edu" educational email for registration) $10
Add to Cart

PLEASE READ:

  • Please contact us at event@sapaweb.org if you have any membership or registration-related questions.
  • Active members, and lifetime members please log in first to enjoy the FREE admission.
  • We encourage you to join SAPA as a member first and immediately enjoy the FREE registration and member benefits for a whole year, including discounts to attend other SAPA events.
  • To enjoy the student discount, please register using your “.edu” school email.

Program at a Glance

Opening Remarks

9:30 am – 9:40 am

Plenary Session

9:40 am – 12:00 pm
Sen Zhuang
Jonathan Cheng
Peixuan Guo
Sen Zhuang, MD, PhDJonathan Cheng, MDPeixuan Guo, PhD
Vice President, Janssen R&DSenior Vice President, Bristol Myers SquibbProfessor, The Ohio State University
9:40 am - 10:20 am10:20 am - 11:00 am11:20 am - 12:00 am
Working Toward a Cure of Multiple Myeloma: A Drug Developer’s PerspectivesThe Evolving Landscape of Immunotherapy Combinations in OncologyThe dynamic, motile and
deformative properties of RNA
nanoparticles lead to efficient
tumor vasculature targeting, fast
renal excretion and rapid body
clearance

Parallel Sessions

1:00 pm – 4:00 pm
Parallel Session 1: Current advances in drug discovery
Songnian Lin
Daohong Zhou
Le Wang
Alan Cheng
Songnian Lin, PhDDaohong Zhou, PhDLe Wang, PhDAlan Cheng, PhD
Director, MerckProfessor, University of Texas Health Science Center at San AntonioPrincipal Research Scientist II, AbbvieDirector, Merck
1:05 pm - 1:45 pm1:45 pm - 2:25 pm2:35 pm - 3:15 pm3:15 pm - 3:55 pm
Novel dimeric insulin: discovery of insulin receptor partial agonists: MK-5160 MK-1092Bcl-xl PROTAC – A safer and more effective antitumor agentDiscovery of ABBV-744, a first-in-class highly BDII selective BET bromodomain inhibitorDeep learning applications in
drug discovery
Parallel Session 2: CMC challenges and solutions in the development of innovative modalities
xuankuo xu phd
Shanmin Kuang
Tong-yuan Yang
Jim Huang
xiaoling li phd
Xuankuo Xu, PhDShanming Kuang, PhDTong-yuan Yang, PhDJim Huang, PhDXiaoling Li, PhD
Director, Bristol Myers SquibbSenior Director, J-Star Research/Porton Pharma SolutionsSenior Scientific Director, Janssen R&DFounder/CEO and Board of Directors, Chair, Ascendia PharmaceuticalsProfessor, University of the Pacific; Cofounder & CSO, Triastek
1:05 pm - 1:40 pm1:40 pm - 2:15 pm2:25 pm - 3:00 pm3:00 pm - 3:35 pm3:35 pm - 4:10 pm
Next generation manufacturing at BMS: adopting a hybrid model for continuous processingCrystallization process development of small molecule drug candidates utilizing solid state knowledgeChallenges and considerations in immunogenicity assessment of cell and gene therapiesNanotechnology platforms for use in drug discovery and developmentMelt extrusion deposition (MED ®) 3D printing for drug delivery, product development and manufacturing
Parallel Session 3: Design, data and digital in drug development
Alex Zhavoronkov_2
Shubing wang
Jorg Wegner
aaron abend mba
Alex Zhavoronkov, PhDShubing Wang, PhDJinbo Lee, PhDJorg Wegner, PhDAaron Abend, MBA
Founder and CEO, Insilico MedicineSenior Principal Scientist, MerckCEO, ScilligenceAssociate Scientific Director, Janssen R&DExecutive Director, Autoimmune Registry
1:05 pm - 1:40 pm1:40 pm - 2:15 pm2:25 pm - 3:00 pm3:00 pm - 3:35 pm3:35 pm - 4:10 pm
End-to-end AI powered drug discovery - why do we need cross-border cooperation to invent better drugs faster?A unified framework of deep computer visionInformatics challenges and opportunities associated with the diversity of drug substancesOpportunities and challenges on “which compounds to make?” and “how to make them?” A scalability perspectivePatients, physicians and the research enterprise
Parallel Session 4: New movements in diagnostics
Yi-Wei Tang
kun shen phd
Andy Wang
Dongfang Liu
Jiemin Yan
Yi-Wei Tang, MD, PhDKui Shen, PhD
Andy Wang, PhDDongfang Liu, PhDJiemin Yan, PhD
Chief Medical Officer, Danaher Dx Platform ChinaDirector, BayerDirector, IVD Product, BGI AmericasAssociate Professor, Rutgers UniversityGM&CEO, Suzhou Astra-biotech
1:05 pm - 1:40 pm1:40 pm - 2:15 pm2:25 pm - 3:00 pm3:00 pm - 3:35 pm3:35 pm - 4:10 pm
Laboratory diagnosis and monitoring of infectious diseases at point of careBayesian hierarchical models for
estimating drug efficacy in companion diagnostic trials
The diagnostic application of metagenomic next-generation sequencing (mNGS) in infectious diseaseIn vitro machine learning-based CAR-T immunological synapse quality measurements correlate with patient clinical outcomesSingle molecular immune solution enables Alzheimer
Disease early screening and
diagnosis

Job Fair and Community Network

4:00 pm – 5:00 pm

Participating companies: Accurant Biotech, Ascendia, GemPharmaTech, and Aleon.

Ascendia Pharmaceuticals open positions: Formulation Scientist/Analytical R&D Scientist/Microbiologist. contact info: HR@ascendiapharma.com.

Aleon open positions: Project Manager, Regulatory Operations Project Management/Project Manager, Regulatory Affairs – Preclinical. contact info: careers@aleonpharma.com.

In-Person Gathering Happy Hours

May 22 2022, 12:00 pm

There will also be in-person gathering and networking events (free of charge) starting at 12:00 pm on May 22, 2022.

*SAPA-HQ meetup location:
Sakura (1345 US-1, North Brunswick Township, NJ 08902); limited to 70 people, thanks to Accurant Biotech Inc. for sponsoring this event.
*SAPA-DC meetup location:
East Dumpling House (12 N Washington St, Rockville, MD 20850).

The instructions for the registration of the in-person events are as follows:
Please check your Confirmation Page/Email after completing the registration for the symposium. The links for further registration of the in-person events are included in the Confirmation Page/Email. Click a link to complete the registration for the in-person event of your choice (As a friendly reminder, if the Confirmation Email is not in your inbox, please check your spam folder).

Participants who have registered for the symposium before May 14th will receive an email reminder and can register for the in-person events directly through the link in the email.

Please contact us at event@sapaweb.org if you have any registration-related questions.

*For everyone’s health and safety, if you are experiencing any COVID-19 symptoms or tested positive within 48 hours of the in personal event, please consider staying home for May 22nd. SAPA will hold more networking events in the future and welcome you to join us next time!

Looking forward to seeing you at the symposium and the in-person gathering event!

Sponsors Information

Thank you for supporting us.

SAPA would like to thank Accurant Biotech for kindly sponsoring the in-person gathering and networking event (May 22 2022 12:00 pm).

Accurant Biotech is a global CRO providing high quality regulated analytical services for clinical trials. With the focus on antibody drug, cell and gene therapeutics, we provide immune- and cell-based analysis for PK, anti-drug antibody, biomarker, receptor occupancy, cell phenotyping, tumor mutation burden, viral detection, etc.  Accurant has 3 GLP labs in New Jersey and China. The detection platforms include chemiluminescence, fluorescence, luminescence, flow cytometry, PCR, immunohistochemistry. Accurant provides full cycle service, from central lab, sample analysis, and data management. Official website: www.accurantbiotech.com

Looking forward to seeing you at the event!